GC Biotech specializes in the research and development of vaccine adjuvants, providing global clients with integrated products, services, and technological solutions. Our scope encompasses everything from raw materials and adjuvant molecules to delivery systems, spanning from discovery to pre - clinical and clinical research stages.

Our goals are as follows:

• Build a more cost - effective capacity for adjuvant and formulation production.
• Become a reliable partner for researchers in human and veterinary vaccines.
• Design and develop vaccine adjuvant systems tailored to various needs.

Our integrated and open - access platform helps reduce R & D costs and accelerate the global delivery of new vaccines. Through technology transfer, technical consultation, and partnership development, we assist our customers in delivering affordable and innovative vaccines to combat various infectious diseases, allergic diseases, and cancers.